4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-17-035824
CIK 0001516479operating
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:26 PM ET
Size
6.7 KB
Accession
0001209191-17-035824
Insider Transaction Report
Form 4
FOURTEAU PATRICK
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-05-26−10,000→ 50,000 totalExercise: $3.63Exp: 2023-05-14→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2017-05-26$3.63/sh+10,000$36,300→ 59,682 total
Footnotes (1)
- [F1]The option was fully vested as of May 14, 2016.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:26 PM ET
- Size
- 6.7 KB